Latest Articles
Anera Life Inc. is proud to announce the appointment of Dr. Dean Raffelock to its Scientific Advisory Board, strengthening the company’s existing scientific leadership and expanding its growing ecosystem of clinical expertise in longevity and cellular health. Anera’s Scientific Advisory Board was created to support the ongoing efforts of our
A new chapter in scientific leadership and the future of longevity. Anera Life Inc. is proud to announce that Dr. Andrew J.M. Willoughby, DMD, LVIF, FAGD, FICOI, FICCMO, FAACFP, MICCMO, has been appointed President of Anera Life Inc., marking a major milestone in the evolution of the company and its
Anera Life is pleased to announce that Dr. Manuel Riegner, MD (Zurich, Switzerland) has officially joined the Anera Scientific Board of Advisors. Dr. Riegner is an internationally recognized physician whose work spans Integrative & Longevity Medicine, Metabolic Psychiatry, Psychoneuroimmunology, and holistic approaches to Personal Development and Transformation. He serves as
On September 29, 2025, the U.S. Food and Drug Administration (FDA) confirmed that β-Nicotinamide Mononucleotide (NMN) is now lawful for use in dietary supplements, marking the end of a three-year period of regulatory uncertainty. This historic reversal came after strong advocacy from the Natural Products Association (NPA), representing a significant
Anera Life is pleased to announce the appointment of Dr. Andrew Willoughby, DMD, LVIF, FAGD, FICCMO, FICOI, FAACFP, MICCMO, as Senior Clinical Advisor. Dr. Willoughby is a surgically trained reconstructive and general dentist with over 37 years of clinical experience. With 92 issued patents to his name, he brings substantial
